IRCCS San Raffaele Roma, 00166 Rome, Italy.
Department of Health Sciences, University "Magna Graecia" of Catanzaro, 88100 Catanzaro, Italy.
Int J Mol Sci. 2024 Nov 8;25(22):11993. doi: 10.3390/ijms252211993.
Irritable bowel syndrome (IBS) is a complex and often debilitating condition that significantly impacts the gastrointestinal system and the overall quality of life of those affected. IBS is characterized by a variety of distressing symptoms, including cramping, abdominal pain, and irregular bowel movements, underlined by an intricate interplay of immune system dysfunction in its pathology. Numerous studies highlight an increased cellular immune response, with elevated levels of proinflammatory cytokines, mucosal alterations due to immune imbalance, and visceral hypersensitivity. Notably, studies indicate increased levels of proinflammatory cytokines, immune imbalances that lead to mucosal changes, and heightened visceral sensitivity. The roles of effector and regulatory T cells are particularly intriguing, as their modification appears to amplify inflammation and may even contribute to autoimmune disorders. This overview of systematic reviews explores the connections between IBS and immune responses, with a focus on immune cell alterations and proliferation of lymphocytes and mast cells in affected individuals. Furthermore, we explore various aspects of IBS management, including its pharmacological approaches. A systematic search of PubMed and Web of Science yielded 676 articles, which were ultimately narrowed down to 9 key studies that met our inclusion criteria. These studies collectively underscore the activation of the immune system with the degranulation of the mast cells in patients with IBS, where the release of inflammatory mediators can compromise intestinal permeability, exacerbating symptoms further. Additionally, we examine the multifaceted management strategies for IBS, emphasizing the potential therapeutic benefits of dietary polyphenols as antioxidants. The present study aims to enhance our understanding of IBS and offer insights into more effective treatment strategies for this challenging condition.
肠易激综合征(IBS)是一种复杂且常使人衰弱的疾病,会对胃肠道系统和受影响人群的整体生活质量造成重大影响。IBS 的特征是各种令人不适的症状,包括痉挛、腹痛和不规则的肠蠕动,其病理学涉及免疫系统功能障碍的复杂相互作用。许多研究强调了细胞免疫反应的增加,促炎细胞因子水平升高,免疫失衡导致的黏膜改变,以及内脏敏感性增加。值得注意的是,研究表明促炎细胞因子水平升高、导致黏膜改变的免疫失衡以及内脏敏感性增加。效应和调节 T 细胞的作用特别有趣,因为它们的改变似乎会放大炎症,甚至可能导致自身免疫性疾病。本综述系统地探讨了 IBS 与免疫反应之间的联系,重点关注免疫细胞改变以及淋巴细胞和肥大细胞在受影响个体中的增殖。此外,我们还探讨了 IBS 管理的各个方面,包括其药理学方法。通过对 PubMed 和 Web of Science 进行系统搜索,共获得 676 篇文章,最终缩小范围到符合纳入标准的 9 项关键研究。这些研究共同强调了 IBS 患者中肥大细胞脱颗粒导致的免疫系统激活,其中炎症介质的释放会损害肠道通透性,进一步加重症状。此外,我们还检查了 IBS 的多方面管理策略,强调了膳食多酚作为抗氧化剂的潜在治疗益处。本研究旨在增进我们对 IBS 的理解,并为这种具有挑战性的疾病提供更有效的治疗策略。